Skip to main content
Top
Published in: Clinical Rheumatology 1/2010

01-01-2010 | Original Article

Fifteen-year experience of pediatric-onset mixed connective tissue disease

Authors: Yi-Ying Tsai, Yao-Hsu Yang, Hsin-Hui Yu, Li-Chieh Wang, Jyh-Hong Lee, Bor-Luen Chiang

Published in: Clinical Rheumatology | Issue 1/2010

Login to get access

Abstract

The aim of this study was to investigate the initial clinical manifestations, laboratory data, complications, and outcomes of patients with pediatric-onset mixed connective tissue disease (MCTD) in Taiwan. We reviewed medical charts of patients younger than 18 years with a diagnosis of mixed connective tissue disease based on the criteria of Kasukawa (1) at the pediatric department of National Taiwan University Hospital from 1993 to 2008. A total of 12 patients were included. All of the patients were female. The mean age at disease onset was 10.7 years (range 6.5 to 14 years). The most common symptoms at disease onset were polyarthritis (7/12 patients) and Raynaud's phenomenon (7/12 patients). The clinical symptoms changed with time, and other symptoms encompassing the criteria for MCTD developed sequentially. Inflammatory manifestations (arthritis, fever, and skin rash) improved following treatment, whereas sclerodermatous features (sclerodactyly, esophageal disease, and vasculopathy) persisted and were often unresponsive to therapy. The organ involvement-free rates at 2 years, 5 years, and 10 years were 91.7%, 78.6%, and 52.4%, respectively. In this retrospective study, sclerodermatous changes of internal organs were a poor prognostic factor in our population, and we emphasize that long-term follow-up is necessary, and appropriate treatment should be applied to improve the outcomes.
Literature
1.
go back to reference Kasukawa RTT, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and antinuclear antibodies. Elsevier, Amsterdam, pp 41–47 Kasukawa RTT, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and antinuclear antibodies. Elsevier, Amsterdam, pp 41–47
2.
3.
go back to reference Burdt MA, Hoffman RW, Deutscher SL et al (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899–909CrossRefPubMed Burdt MA, Hoffman RW, Deutscher SL et al (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899–909CrossRefPubMed
4.
go back to reference Sharp GC, Irvin WS, Tan EM et al (1972) Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159CrossRefPubMed Sharp GC, Irvin WS, Tan EM et al (1972) Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159CrossRefPubMed
5.
go back to reference Hoffman RW, Cassidy JT, Takeda Y et al (1993) U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis. Arthritis Rheum 36:1599–1602CrossRefPubMed Hoffman RW, Cassidy JT, Takeda Y et al (1993) U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis. Arthritis Rheum 36:1599–1602CrossRefPubMed
6.
go back to reference Mier RJ, Shishov M, Higgins GC et al (2005) Pediatric-onset mixed connective tissue disease. Rheum Dis Clin North Am 31:483–496 viiCrossRefPubMed Mier RJ, Shishov M, Higgins GC et al (2005) Pediatric-onset mixed connective tissue disease. Rheum Dis Clin North Am 31:483–496 viiCrossRefPubMed
7.
go back to reference Singsen BH, Bernstein BH, Kornreich HK et al (1997) Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr 90:893–900 Singsen BH, Bernstein BH, Kornreich HK et al (1997) Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr 90:893–900
8.
go back to reference Tiddens HA, van der Net JJ, de Graeff-Meeder ER et al (1993) Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J Pediatr 122:191–197CrossRefPubMed Tiddens HA, van der Net JJ, de Graeff-Meeder ER et al (1993) Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J Pediatr 122:191–197CrossRefPubMed
9.
go back to reference van der Net J, van der Hoeven H, Esseveld F et al (1995) Musculoskeletal disorders in juvenile onset mixed connective tissue disease. J Rheumatol 22:751–757PubMed van der Net J, van der Hoeven H, Esseveld F et al (1995) Musculoskeletal disorders in juvenile onset mixed connective tissue disease. J Rheumatol 22:751–757PubMed
10.
go back to reference Swart JF, Wulffraat NM (2008) Diagnostic workup for mixed connective tissue disease in childhood. Isr Med Assoc J 10:650–652PubMed Swart JF, Wulffraat NM (2008) Diagnostic workup for mixed connective tissue disease in childhood. Isr Med Assoc J 10:650–652PubMed
11.
go back to reference Doria A, Bonavina L, Anselmino M et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed Doria A, Bonavina L, Anselmino M et al (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690PubMed
12.
go back to reference Graf WD, Milstein JM, Sherry DD (1993) Stroke and mixed connective tissue disease. J Child Neurol 8:256–259CrossRefPubMed Graf WD, Milstein JM, Sherry DD (1993) Stroke and mixed connective tissue disease. J Child Neurol 8:256–259CrossRefPubMed
13.
go back to reference Dungan DD, Jay MS (1992) Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics 90:96–99PubMed Dungan DD, Jay MS (1992) Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics 90:96–99PubMed
14.
go back to reference Hirasaki S, Koide N, Ogawa H et al (1997) Mixed connective tissue disease associated with idiopathic portal hypertension and chronic thyroiditis. J Gastroenterol 32:808–811CrossRefPubMed Hirasaki S, Koide N, Ogawa H et al (1997) Mixed connective tissue disease associated with idiopathic portal hypertension and chronic thyroiditis. J Gastroenterol 32:808–811CrossRefPubMed
15.
go back to reference Tsuneyama K, Harada K, Katayanagi K et al (2002) Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol 17:217–223CrossRefPubMed Tsuneyama K, Harada K, Katayanagi K et al (2002) Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol 17:217–223CrossRefPubMed
16.
go back to reference Savouret JF, Chudwin DS, Wara DW et al (1983) Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1. J Pediatr 102:841–846CrossRefPubMed Savouret JF, Chudwin DS, Wara DW et al (1983) Clinical and laboratory findings in childhood mixed connective tissue disease: presence of antibody to ribonucleoprotein containing the small nuclear ribonucleic acid U1. J Pediatr 102:841–846CrossRefPubMed
17.
go back to reference Igarashi A, Nashiro K, Kikuchi K et al (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729–733CrossRefPubMed Igarashi A, Nashiro K, Kikuchi K et al (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729–733CrossRefPubMed
18.
go back to reference Robalino BD, Moodie DS (1991) Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 17:492–498PubMedCrossRef Robalino BD, Moodie DS (1991) Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 17:492–498PubMedCrossRef
19.
go back to reference Rai T, Ohira H, Fukaya E et al (2004) A case of merged idiopathic portal hypertension in course of mixed connective tissue disease. Hepatol Res 30:51–55CrossRefPubMed Rai T, Ohira H, Fukaya E et al (2004) A case of merged idiopathic portal hypertension in course of mixed connective tissue disease. Hepatol Res 30:51–55CrossRefPubMed
20.
go back to reference Kotajima L, Aotsuka S, Sumiya M et al (1996) Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J Rheumatol 23:1088–1094PubMed Kotajima L, Aotsuka S, Sumiya M et al (1996) Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan. J Rheumatol 23:1088–1094PubMed
21.
go back to reference Oetgen WJ, Boice JA, Lawless OJ (1981) Mixed connective tissue disease in children and adolescents. Pediatrics 67:333–337PubMed Oetgen WJ, Boice JA, Lawless OJ (1981) Mixed connective tissue disease in children and adolescents. Pediatrics 67:333–337PubMed
22.
go back to reference de Rooij DJ, Fiselier T, van de Putte LB et al (1989) Juvenile-onset mixed connective tissue disease: clinical, serological and follow-up data. Scand J Rheumatol 18:157–160CrossRefPubMed de Rooij DJ, Fiselier T, van de Putte LB et al (1989) Juvenile-onset mixed connective tissue disease: clinical, serological and follow-up data. Scand J Rheumatol 18:157–160CrossRefPubMed
Metadata
Title
Fifteen-year experience of pediatric-onset mixed connective tissue disease
Authors
Yi-Ying Tsai
Yao-Hsu Yang
Hsin-Hui Yu
Li-Chieh Wang
Jyh-Hong Lee
Bor-Luen Chiang
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1276-y

Other articles of this Issue 1/2010

Clinical Rheumatology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine